KLAS THERAPEUTICS LIMITED

NI676570
Active Belfast

Other research and experimental development on natural sciences and engineering

4 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineeringOther professional, scientific and technical activities n.e.c.
K

KLAS THERAPEUTICS LIMITED

NI676570

Other research and experimental development on natural sciences and engineering

Founded 16 Feb 2021 Active Belfast, United Kingdom 4 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineeringOther professional, scientific and technical activities n.e.c.
Accounts Submitted 27 May 2026 Next due 30 Nov 2026 5 months remaining
Confirmation Submitted 24 Feb 2026 Next due 1 Mar 2027 8 months remaining
Net assets £-80K £6K 2024 year on year
Total assets £200K £140K 2024 year on year
Total Liabilities £280K £147K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

C/O Cleaver Fulton Rankin 50 Bedford Street Belfast BT2 7FW United Kingdom

Website

www.example.com

Full company profile for KLAS THERAPEUTICS LIMITED (NI676570), an active life sciences and medical technology company based in Belfast, United Kingdom. Incorporated 16 Feb 2021. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Mar → 28 Feb 2025
Type total-exemption-full
Next accounts 28 Feb 2026
Due by 30 Nov 2026 5 months remaining

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£102.70k

Increased by £54.78k (+114%)

Net Assets

-£80.09k

Decreased by £6.43k (-9%)

Total Liabilities

£279.70k

Increased by £146.64k (+110%)

Turnover

N/A

Employees

4

Increased by 2 (+100%)

Debt Ratio

140%

Decreased by 84 (-38%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
28 Feb Year End
2024
29 Feb Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 112,010 Shares £122 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
17 Sept 202420,000£20£0.001
7 Feb 202492,000£92£0.001
10 Mar 202210£10£1

Officers

Officers

2 active 1 resigned
Status
Brundle, Timothy JohnDirectorIrishNorthern Ireland537 Feb 2024Active
Callan, John, ProfessorDirectorBritishNorthern Ireland5316 Feb 2021Active

Shareholders

Shareholders (6)

Bridgeen Callan
36.5%
70,000
Innovation Ulster Limited
21.9%
42,000

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Professor Bridgeen Callan

Northern Irish

Active
Notified 16 Feb 2021
Residence Northern Ireland
DOB August 1979
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 May 2026AccountsAnnual accounts made up to 28 Feb 2026
24 Feb 2026Confirmation StatementConfirmation statement made on 15 Feb 2026 with no updates
17 Jun 2025AccountsAnnual accounts made up to 28 Feb 2025
25 Feb 2025Confirmation StatementConfirmation statement made on 15 Feb 2025 with updates
24 Feb 2025OfficersChange to director Dr Bridgeen Callan on 24 Feb 2025
27 May 2026 Accounts

Annual accounts made up to 28 Feb 2026

24 Feb 2026 Confirmation Statement

Confirmation statement made on 15 Feb 2026 with no updates

17 Jun 2025 Accounts

Annual accounts made up to 28 Feb 2025

25 Feb 2025 Confirmation Statement

Confirmation statement made on 15 Feb 2025 with updates

24 Feb 2025 Officers

Change to director Dr Bridgeen Callan on 24 Feb 2025

Recent Activity

Latest Activity

Annual accounts made up to 28 Feb 2026

1 months ago on 27 May 2026

Confirmation statement made on 15 Feb 2026 with no updates

4 months ago on 24 Feb 2026

Annual accounts made up to 28 Feb 2025

1 years ago on 17 Jun 2025

Confirmation statement made on 15 Feb 2025 with updates

1 years ago on 25 Feb 2025

Change to director Dr Bridgeen Callan on 24 Feb 2025

1 years ago on 24 Feb 2025